Highlights of Vitreoretina

Register      Login

VOLUME 7 , ISSUE 1 ( March, 2014 ) > List of Articles


Manifestaciones Vasculares Retinianas: ¿Reflejan el Estado del Corazón?

Gerald Liewa, Jie Jin Wangba

Citation Information : Liewa G, Wangba JJ. Manifestaciones Vasculares Retinianas: ¿Reflejan el Estado del Corazón?. 2014; 7 (1):8-12.

DOI: 10.5005/hov-10102-07102

Published Online: 26-12-2020

Copyright Statement:  Copyright © 2014; Jaypee Brothers Medical Publishers (P) Ltd.


PDF Share
  1. Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med. 2007;356:830-40.
  2. Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci. 2003;4:399-415.
  3. Cannon RO, Camici PG, Epstein SE. Pathophysiological dilemma of syndrome X. Circulation. 1992;85:883-92.
  4. Maseri A, Crea F, Kaski JC, Crake T. Mechanisms of angina pectoris in syndrome X. J Am Coll Cardiol. 1991;17:499-506.
  5. Van der Worp HB, Van Gijn J. Clinical practice. Acute ischemic stroke. N Engl J Med. 2007;357:572-9.
  6. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991;337:1521-6.
  7. Lammie GA. Pathology of small vessel stroke. Br Med Bull. 2000;56:296-306.
  8. Lammie GA, Brannan F, Slattery J, Warlow C. Nonhypertensive cerebral small-vessel disease. An autopsy study. Stroke. 1997;28:2222-9.
  9. Fisher CM. Lacunes: small, deep cerebral infarcts. Neurology. 1965;15:774-84.
  10. Wong TY, McIntosh R. Systemic associations of retinal microvascular signs: a review of recent population-based studies. Ophthalmic Physiol Opt. 2005;25:195-204.
  11. Wong TY, McIntosh R. Hypertensive retinopathy signs as risk indicators of cardiovascular morbidity and mortality. Br Med Bull. 2005;73-74:57-70.
  12. Tso MO, Jampol LM. Pathophysiology of hypertensive retinopathy. Ophthalmology. 1982;89:1132- 45.
  13. Wong TY, Knudtson MD, Klein R, Klein BE, Meuer SM, Hubbard LD. Computer-assisted measurement of retinal vessel diameters in the Beaver Dam Eye Study: methodology, correlation between eyes, and effect of refractive errors. Ophthalmology. 2004;111:1183-90.
  14. Wong TY, Mitchell P. The eye in hypertension. Lancet. 2007;369:425-35.
  15. Wong TY, Mitchell P. Hypertensive retinopathy. N Engl J Med. 2004;351:2310-7.
  16. Klein R. Retinopathy in a population-based study. Trans Am Ophthalmol Soc. 1992;90:561-94.
  17. Klein R, Klein BE, Moss SE, Wang Q. Blood pressure, hypertension and retinopathy in a population. Trans Am Ophthalmol Soc. 1993;91:207-22.
  18. Klein R, Klein BE, Moss SE, Wang Q. Hypertension and retinopathy, arteriolar narrowing, and arteriovenous nicking in a population. Arch Ophthalmol. 1994;112:92-8.
  19. Wang JJ, Mitchell P, Leung H, Rochtchina E, Wong TY, Klein R. Hypertensive retinal vessel wall signs in a general older population: the Blue Mountains Eye Study. Hypertension. 2003;42:534- 41.
  20. Klein R, Klein BE, Moss SE. The relation of systemic hypertension to changes in the retinal vasculature: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc. 1997;95:329-48. Medline
  21. Klein R, Myers CE, Lee KE, Klein BE. 15-year cumulative incidence and associated risk factors for retinopathy in nondiabetic persons. Arch Ophthalmol. 2010;128:1568-75.
  22. Cugati S, Cikamatana L, Wang JJ, Kifley A, Liew G, Mitchell P. Five-year incidence and progression of vascular retinopathy in persons without diabetes: the Blue Mountains Eye Study. Eye. 2005;20:1239-45.
  23. Ashton N, Peltier S, Garner A. Experimental hypertensive retinopathy in the monkey. Trans Ophthalmol Soc UK. 1969;88:167-86. Medline
  24. Garner A, Ashton N, Tripathi R, Kohner EM, Bulpitt CJ, Dollery CT. Pathogenesis of hypertensive retinopathy. An experimental study in the monkey. Br J Ophthalmol. 1975;59:3-44.
  25. Tanaka M, Fujiwara H, Onodera T, Wu DJ, Matsuda M, Hamashima Y, et al. Quantitative analysis of narrowings of intramyocardial small arteries in normal hearts, hypertensive hearts, and hearts with hypertrophic cardiomyopathy. Circulation. 1987;75:1130-9.
  26. Mosseri M, Yarom R, Gotsman MS, Hasin Y. Histologic evidence for small-vessel coronary artery disease in patients with angina pectoris and patent large coronary arteries. Circulation. 1986;74:964-72.
  27. Rizzoni D, Porteri E, Boari GE, De Ciuceis C, Sleiman I, Muiesan ML, et al. Prognostic significance of small-artery structure in hypertension. Circulation. 2003;108:2230-5.
  28. De Ciuceis C, Porteri E, Rizzoni D, Rizzardi N, Paiardi S, Boari GE, et al. Structural alterations of subcutaneous small-resistance arteries may predict major cardiovascular events in patients with hypertension. Am J Hypertens. 2007;20:846-52.
  29. Schiffrin EL, Park JB, Intengan HD, Touyz RM. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. Circulation. 2000;101:1653-9.
  30. Park JB, Schiffrin EL. Small artery remodeling is the most prevalent form of target organ damage in mild essential hypertension. J Hypertens. 2001;19:921-30.
  31. Lindley RI, Wang JJ, Wong MC, Mitchell P, Liew G, Hand P, et al. Retinal microvasculature in acute lacunar stroke: a cross-sectional study. Lancet Neurol. 2009;8:628-34.
  32. Doubal FN, Macgillivray TJ, Hokke PE, Dhillon B, Dennis MS, Wardlaw JM. Differences in retinal vessels support a distinct vasculopathy causing lacunar stroke. Neurology. 2009;72:1773-8.
  33. Wang L, Wong TY, Sharrett AR, Klein R, Folsom AR, Jerosch-Herold M. Relationship between retinal arteriolar narrowing and myocardial perfusion: multi-ethnic study of atherosclerosis. Hypertension. 2008;51:119-26.
  34. Wong TY, Cheung N, Islam FM, Klein R, Criqui MH, Cotch MF, et al. Relation of retinopathy to coronary artery calcification: the multi-ethnic study of atherosclerosis. Am J Epidemiol. 2008;167:51-8.
  35. Tedeschi-Reiner E, Strozzi M, Skoric B, Reiner Z. Relation of atherosclerotic changes in retinal arteries to the extent of coronary artery disease. Am J Cardiol. 2005;96:1107-9.
  36. Touyz RM. Vascular remodeling, retinal arteries, and hypertension. Hypertension. 2007;50:603-4.
  37. Sharrett AR, Hubbard LD, Cooper LS, Sorlie PD, Brothers RJ, Nieto FJ, et al. Retinal arteriolar diameters and elevated blood pressure: the Atherosclerosis Risk in Communities Study. Am J Epidemiol. 1999;150:263-70.
  38. Leung H, Wang JJ, Rochtchina E, Wong TY, Klein R, Mitchell P. Impact of current and past blood pressure on retinal arteriolar diameter in an older population. J Hypertens. 2004;22:1543-9.
  39. Wong TY, Islam FM, Klein R, Klein BE, Cotch MF, Castro C, et al. Retinal vascular caliber, cardiovascular risk factors, and inflammation: the multi-ethnic study of atherosclerosis (MESA). Invest Ophthalmol Vis Sci. 2006;47:2341-50.
  40. Klein R, Klein BE, Knudtson MD, Wong TY, Tsai MY. Are inflammatory factors related to retinal vessel caliber? The Beaver Dam Eye Study. Arch Ophthalmol. 2006;124:87-94. Medline
  41. Klein R, Sharrett AR, Klein BE, Chambless LE, Cooper LS, Hubbard LD, et al. Are retinal arteriolar abnormalities related to atherosclerosis?: The Atherosclerosis Risk in Communities Study. Arterioscler Thromb Vasc Biol. 2000;20:1644-50.
  42. kram MK, De Jong FJ, Vingerling JR, Witteman JC, Hofman A, Breteler MM, et al. Are retinal arteriolar or venular diameters associated with markers for cardiovascular disorders? The Rotterdam Study. Invest Ophthalmol Vis Sci. 2004;45:2129-34.
  43. Wong TY, Hubbard LD, Klein R, Marino EK, Kronmal R, Sharrett AR, et al. Retinal microvascular abnormalities and blood pressure in older people: the Cardiovascular Health Study. Br J Ophthalmol. 2002;86:1007-13.
  44. De Jong FJ, Vernooij MW, Ikram MK, Ikram MA, Hofman A, Krestin GP, et al. Arteriolar oxygen saturation, cerebral blood flow, and retinal vessel diameters. The Rotterdam Study. Ophthalmology. 2007;115:887-92.
  45. Ikram MK, Janssen JA, Roos AM, Rietveld I, Witteman JC, Breteler MM, et al. Retinal vessel diameters and risk of impaired fasting glucose or diabetes: the Rotterdam study. Diabetes. 2006;55:506-10.
  46. Nguyen TT, Wong TY. Retinal vascular manifestations of metabolic disorders. Trends Endocrinol Metab. 2006;17:262-8.
  47. Wong TY. Is retinal photography useful in the measurement of stroke risk?. Lancet Neurol. 2004;3:179-83.
  48. Wong TY, Klein R, Sharrett AR, Duncan BB, Couper DJ, Tielsch JM, et al. Retinal arteriolar narrowing and risk of coronary heart disease in men and women. The Atherosclerosis Risk in Communities Study. JAMA. 2002;287:1153-9.
  49. Wang JJ, Liew G, Wong TY, Smith W, Klein R, Leeder S, et al. Retinal vascular caliber and the risk of coronary heart disease-related mortality. Heart. 2006;92:1583-7.
  50. Wong TY, Knudtson MD, Klein R, Klein BE, Hubbard LD. A prospective cohort study of retinal arteriolar narrowing and mortality. Am J Epidemiol. 2004;159:819-25.
  51. Wang JJ, Liew G, Klein R, Rochtchina E, Knudtson MD, Klein BE, et al. Retinal vessel diameter and cardiovascular mortality: pooled data analysis from two older populations. Eur Heart J. 2007;28:1984-92.
  52. Wong TY, Klein R, Nieto FJ, Klein BE, Sharrett AR, Meuer SM, et al. Retinal microvascular abnormalities and 10-year cardiovascular mortality: a population-based case-control study. Ophthalmology. 2003;110:933-40.
  53. McGeechan K, Liew G, Macaskill P, Irwig L, Klein R, Klein BE, et al. Meta-analysis: retinal vessel caliber and risk for coronary heart disease. Ann Intern Med. 2009;151:404-13.
  54. Pepine CJ, Kerensky RA, Lambert CR, Smith KM, Von Mering GO, Sopko G, et al. Some thoughts on the vasculopathy of women with ischemic heart disease. J Am Coll Cardiol. 2006;47(Suppl 3):S30-S305.
  55. Bugiardini R, Bairey Merz CN. Angina with “normal” coronary arteries: a changing philosophy. JAMA. 2005;293:477-84.
  56. Buchthal SD, Den Hollander JA, Merz CN, Rogers WJ, Pepine CJ, Reichek N, et al. Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms. N Engl J Med. 2000;342:829-35.
  57. Bairey Merz CN, Shaw LJ, Reis SE, Bittner V, Kelsey SF, Olson M, et al. Insights from the NHLBI Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol. 2006;47(Suppl 3):S21-9.
  58. Liew G, Wang JJ, Mitchell P, Wong TY. Retinal vascular imaging: a new tool in microvascular disease research. Circ Cardiovasc Imaging. 2008;1:156-61.
  59. Cheung N, Sharrett AR, Klein R, Criqui MH, Islam FM, Macura KJ, et al. Aortic distensibility and retinal arteriolar narrowing: the multi-ethnic study of atherosclerosis. Hypertension. 2007;50:617- 22.
  60. Cheung N, Islam FM, Jacobs DR, Sharrett AR, Klein R, Polak JF, et al. Arterial compliance and retinal vascular caliber in cerebrovascular disease. Ann Neurol. 2007;62:618-24.
  61. McGeechan K, Liew G, Macaskill P, Irwig L, Klein R, Sharrett AR, et al. Risk prediction of coronary heart disease based on retinal vascular caliber (from the Atherosclerosis Risk In Communities [ARIC] Study). Am J Cardiol. 2008;102:58-63.
  62. Cheung N, Wang JJ, Klein R, Couper DJ, Richey Sharrett AR, Wong TY. Diabetic retinopathy and the risk of coronary heart disease: the Atherosclerosis Risk in Communities Study. Diabetes Care. 2007;30:1742-6.
  63. Miettinen H, Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Retinopathy predicts coronary heart disease events in NIDDM patients. Diabetes Care. 1996;19:1445-8.
  64. Targher G, Bertolini L, Tessari R, Zenari L, Arcaro G. Retinopathy predicts future cardiovascular events among type 2 diabetic patients: The Valpolicella Heart Diabetes Study. Diabetes Care. 2006;29:1178.
  65. Turner RC, Millns H, Neil HA, Stratton IM, Manley SE, Matthews DR, et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ. 1998;316:823-8.
  66. Liew G, Wong TY, Mitchell P, Cheung N, Wang JJ. Retinopathy predicts coronary heart disease mortality. Heart. 2009;95:391-4.
  67. Van Hecke MV, Dekker JM, Nijpels G, Moll AC, Van Leiden HA, Heine RJ, et al. Retinopathy is associated with cardiovascular and all-cause mortality in both diabetic and nondiabetic subjects: the hoorn study. Diabetes Care. 2003;26:2958.
  68. Cugati S, Wang JJ, Knudtson MD, Rochtchina E, Klein R, Klein BE, et al. Retinal vein occlusion and vascular mortality: pooled data analysis of 2 population-based cohorts. Ophthalmology. 2007;114:520-4.
  69. Christoffersen N, Gade E, Knudsen L, Juel K, Larsen M. Mortality in patients with branch retinal vein occlusion. Ophthalmology. 2007;114:1186-9.
  70. Klein R, Klein BE, Moss SE, Meuer SM. Retinal emboli and cardiovascular disease: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc. 2003;101:173-80.
  71. Wang JJ, Cugati S, Knudtson MD, Rochtchina E, Klein R, Klein BE, et al. Retinal arteriolar emboli and long-term mortality: pooled data analysis from two older populations. Stroke. 2006;37:1833- 6.
  72. Thyer I, Kovoor P, Wang JJ, Taylor B, Kifley A, Lindley R, et al. Coronary catheterisation does not lead to retinal artery emboli in short-term follow-up of cardiac patients. Stroke. 2007;38:2370-2.
  73. Kreis AJ, Nguyen T, Rogers S, Wang JJ, Harper CA, Clark DJ, et al. Acute retinal arteriolar emboli after cardiac catheterization. Stroke. 2008;39:3086-7.
  74. Kanski JJ. Drug-induced disorders.
  75. Nieminen T, Lehtimaki T, Maenpaa J, Ropo A, Uusitalo H, Kahonen M. Ophthalmic timolol: plasma concentration and systemic cardiopulmonary effects. Scand J Clin Lab Invest. 2007;67:237-45.
  76. Lee AJ, Wang JJ, Kifley A, Mitchell P. Open-angle glaucoma and cardiovascular mortality: the Blue Mountains Eye Study. Ophthalmology. 2006;113:1069-76.
  77. Lama PJ. Topical beta-adrenergic blockers and glaucoma: a heart-stopping association? Ophthalmology. 2006;113:1067-8.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.